Dr Salah Mansour is an Associate Professor at the University of Southampton. His research focuses on unconventional T cells, particularly CD1-restricted and invariant natural killer T (iNKT) cells, and their application in cancer immunotherapy and infectious disease. His work combines structural biology, single-cell multiomics, and translational immunology to develop next-generation, off-the-shelf cell therapies for cancer, with a particular focus on acute myeloid leukaemia.